Company Overview of Aerovance, Inc.
Aerovance, Inc., a biopharmaceutical company, engages in the development and commercialization of medicines for respiratory and allergic diseases. The company offers Aerovant, a novel molecule that targets the root cause of asthma by blocking Th2 allergic inflammation; Aeroderm, which is formulated for the treatment of atopic eczema; Aerolytic that is used for the treatment of cystic fibrosis; and Pulmolytic, which is used for the treatment of chronic obstructive pulmonary disease. Aerovance, Inc. was founded in 2004 and is based in Berkeley, California.
2929 7th Street
Berkeley, CA 94710
Founded in 2004
Key Executives for Aerovance, Inc.
Similar Private Companies By Industry
|Particle Sciences, Inc.||United States|
|Clarus Therapeutics, Inc.||United States|
|Warner Chilcott Holdings Company III, Limited||United States|
|Nektar Therapeutics Al, Corp||United States|
|Eyetech Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Aerovance, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.